Regarding copeptin as a candidate for inclusion in a biomarker panel aimed at prognosticating short-term stroke outcomes, Tu et al. [31] studied 189 patients after an acute ischemic stroke and observed that the early measurement of plasma copeptin levels may serve as an independent prognostic outcome predictor with the greatest prognostic potential among the biomarkers under research. Here, AVP is linked to stroke disorder.